Adenocarcinoma patients who undergo chemotherapy and surgery experience significantly improved survival rates when their tumor is lacking the retinoblastoma tumor suppressor protein, new research shows. This new information is very useful as it may predict which patients will respond best to chemotherapy.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1kdoqF2
No comments:
Post a Comment